Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trial
1. 系统已在2025-04-02 17:45:40对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S1470-2045(25)00001-4
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204525000014
其他信息:
出版社: Elsevier BV
作者: Takehito Shukuya; Tetsuhiko Asao; Yasushi Goto; Tomoyasu Mimori; Koichi Takayama; Kyoichi Kaira; Hiroshi Tanaka; Ryo Ko; Yoshihiro Amano; Motoko Tachihara; Takuji Suzuki; Junko Tanizaki; Shunichi Sugawara; Yoshitaka Zenke; Yukina Shirai; Takuo Hayashi; Keita Mori; Kazuhisa Takahashi